Christopher M. Haqq
Affiliations: | University of California San Francisco and Gladstone Institutes |
Google:
"Christopher Haqq"Mean distance: (not calculated yet)
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Magbanua MJ, Wolf DM, Yau C, et al. (2015) Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response. Breast Cancer Research : Bcr. 17: 73 |
Lang JE, Scott JH, Wolf DM, et al. (2015) Expression profiling of circulating tumor cells in metastatic breast cancer. Breast Cancer Research and Treatment. 149: 121-31 |
Taplin ME, Montgomery B, Logothetis CJ, et al. (2014) Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3705-15 |
Magbanua MJ, Richman EL, Sosa EV, et al. (2014) Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes & Control : Ccc. 25: 515-23 |
Harland S, Staffurth J, Molina A, et al. (2013) Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy. European Journal of Cancer (Oxford, England : 1990). 49: 3648-57 |
Ryan CJ, Molina A, Li J, et al. (2013) Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2791-8 |
Logothetis CJ, Basch E, Molina A, et al. (2012) Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. The Lancet. Oncology. 13: 1210-7 |
Magbanua MJ, Roy R, Sosa EV, et al. (2011) Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. Plos One. 6: e24004 |
Ryan CJ, Shah S, Efstathiou E, et al. (2011) Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4854-61 |
de Bono JS, Logothetis CJ, Molina A, et al. (2011) Abiraterone and increased survival in metastatic prostate cancer. The New England Journal of Medicine. 364: 1995-2005 |